Terns Pharmaceuticals, Inc. (TERN)

Terns Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	79.93	143.24	47.7	74.85	12.33
Short-Term Investments	183.51	139.88	118.28	12.72	7.32
Cash & Cash Equivalents	263.44	283.11	165.98	87.57	19.65
Cash Growth	-6.95%	70.57%	89.54%	345.66%	-77.38%
Other Current Assets	3.99	2.07	0.95	3.3	2.57
Total Current Assets	267.43	285.19	166.93	90.87	22.22
Property, Plant & Equipment	1.03	1.8	1.05	1.18	0.96
Other Long-Term Assets	0.06	0.04	0.09	0.25	0.72
Total Long-Term Assets	1.09	1.84	1.14	1.42	1.68
Total Assets	268.52	287.03	168.07	92.29	23.9
Accounts Payable	2.52	1.65	2.13	0.94	1.64
Current Debt	0.6	0.66	0	12.88	0
Other Current Liabilities	8.83	6.16	4.69	9.01	3.31
Total Current Liabilities	11.94	8.47	6.82	22.82	4.95
Long-Term Debt	0	0.54	0	0	0
Other Long-Term Liabilities	1.21	1.07	0.95	0.88	0.63
Total Long-Term Liabilities	1.21	1.62	0.95	0.88	0.63
Total Liabilities	13.15	10.08	7.77	23.7	5.58
Total Debt	0.6	1.21	0	12.88	0
Debt Growth	-49.96%	-	-	-	-
Retained Earnings	-332.63	-242.42	-182.07	-131.92	-91.86
Comprehensive Income	-0.02	-0.82	-0.34	-0.12	-0.11
Shareholders' Equity	255.37	276.94	160.3	-117.44	-104.88
Net Cash / Debt	262.84	281.91	165.98	74.69	19.65
Net Cash / Debt Growth	-6.77%	69.84%	122.22%	280.11%	-77.38%
Net Cash Per Share	3.69	7.82	7.31	261.93	107.22
Working Capital	255.49	276.72	160.11	68.05	17.27
Book Value Per Share	3.58	7.69	7.06	-411.84	-572.28

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).